Skip to content

Agreement of total corneal power measured by CASIA 2, Pentacam AXL, and IOLMaster 700 in normal and keratoconus patients

Agreement of total corneal power measured by CASIA 2, Pentacam AXL, and IOLMaster 700 in normal and keratoconus patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210608001
Enrollment
134
Registered
2021-06-08
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total corneal power measured by CASIA 2, Pentacam AXL, and IOLMaster 700 in normal and keratoconus patients CASIA 2, Pentacam AXL, IOLMaster 700, total corneal power, optical biometry, IOL calculation, keratoconus

Interventions

Healthy participants at Outpatient unit, Department of Ophthalmology, King Chulalongkorn Memorial Hospital,Keratoconus patients at Outpatient unit, Department of Ophthalmology, King Chulalongkorn Memo
Diagnostic,Diagnostic
Normal group,Keratoconus group

Sponsors

Ratchadapiseksomphot Endowment Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Normal group 1 Healthy participants 2 Age 18 years old or more 3 Able to read, understand and sign an informed consent form Keratoconus group 1 Participants with diagnosed keratoconus by corneal specialist based on both 1.1 Topography or tomography pattern characteristic with abnormal posterior elevation, abnormal corneal thickness 1.2 At least one keratoconus clinical findings on slit lamp examination, corneal stromal thinning, Fleischer ring, and Vogts striae 2 Mild to moderate severity of keratoconus stage 1, 2, 3 by Amsler Krumeich keratoconus classification 3 Subclinical keratoconus or forme fruste keratoconus based on corneal topography pattern characteristic without clinical findings

Exclusion criteria

Exclusion criteria: Normal group 1 Participants who have ocular pathology 1.1 Corneal disease, including severe dry eye, corneal opacity, pterygium 1.2 Retina or macular disease 1.3 Strabismus or nystagmus 2 Previous ocular surgery or refractive surgery 3 Previous ocular trauma Keratoconus group 1 Participants who have ocular pathology 1.1 Other corneal disease 1.2 History of acute hydrops and corneal scarring 1.3 Retina or macular disease 2 Previous ocular surgery or refractive surgery 3 Previous ocular trauma

Design outcomes

Primary

MeasureTime frame
Total corneal power At the day of measurement Agreement between devices by ICC and Bland-Altman plot

Secondary

MeasureTime frame
Total corneal astigmatism At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Anterior keratometry At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Anterior corneal astigmatism At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Posterior keratometry At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Posterior corneal astigmatism At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Anterior chamber depth At the day of measurement Agreement between devices by ICC and Bland-Altman plot,White to white At the day of measurement Agreement between devices by ICC and Bland-Altman plot,Central corneal thickness At the day of measurement Agreement between devices by ICC and Bland-Altman plot,IOL power At the day of measurement Agreement between devices by ICC and Bland-Altman plot

Countries

Thailand

Contacts

Public ContactRusaporn Yodying

Department of Ophthalmology, King Chulalongkorn Memorial Hospital

rosepornyy@gmail.com0815842999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026